Paper Details
- Home
- Paper Details
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
Author: HepnerAdrian, PopeLaura E, ShaibaniAziz I, ThistedRonald
Original Abstract of the Article :
OBJECTIVE: To evaluate dextromethorphan coadministered with quinidine as treatment of diabetic peripheral neuropathic pain. DESIGN: In a 13-week, phase 3, randomized controlled trial, 379 adults with daily symmetric diabetic peripheral neuropathy (DPN) leg pain for ≥3 months received double-blind p...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/j.1526-4637.2011.01316.x
データ提供:米国国立医学図書館(NLM)
Dextromethorphan/Quinidine for Diabetic Neuropathic Pain
This study dives into the world of diabetic peripheral neuropathic pain (DPN), a condition that can feel like a desert storm raging inside your body. It explores the effectiveness of dextromethorphan/quinidine (DMQ) as a treatment for this painful condition.
The researchers used a double-blind, placebo-controlled, multicenter study, which is like a treasure hunt in a vast desert, where you have to carefully evaluate the clues to find the truth. They found that DMQ was superior to placebo in reducing pain, as measured by various pain rating scales. Imagine a group of travelers crossing a desert, and DMQ is like a magical oasis that provides relief from the scorching sun and scorching pain.
DMQ 45/30 mg was found to be more effective than DMQ 30/30 mg, suggesting that the dosage matters. The study also reported some adverse events, which is like encountering sandstorms and mirages in the desert, but these were mostly mild or moderate. The researchers concluded that DMQ is an effective treatment for DPN, but further research is needed to improve tolerability while maintaining efficacy.
The Potential of Dextromethorphan/Quinidine
These findings suggest that DMQ could offer relief to millions of individuals suffering from DPN. The results of the study, with its careful methodology and consistent findings, provide a beacon of hope for those struggling with this debilitating condition. The future holds the promise of a more tolerable and effective DMQ formulation, which could transform the lives of many patients.
The Importance of Pain Management
Living with chronic pain can feel like being trapped in a never-ending sandstorm. DPN can significantly affect quality of life, making it difficult to carry out daily tasks and enjoy life's simple pleasures. This study highlights the importance of effective pain management and provides valuable insights into potential therapeutic solutions. Understanding the complexities of pain and exploring innovative treatments like DMQ is crucial for improving the well-being of individuals suffering from chronic pain.
Dr. Camel's Conclusion
This research represents a significant step forward in the search for effective treatment options for diabetic peripheral neuropathic pain. It's like finding a hidden oasis in the vast desert of chronic pain. With further refinement, DMQ has the potential to become a valuable tool for pain management and improve the lives of countless people.
Date :
- Date Completed 2012-11-06
- Date Revised 2022-04-09
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.